Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
2,231 people get PDLI articles and Market Currents by email alert.
Get email alerts on PDLI »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
PR Newswire (May 9, 2013)
-
-
-
PR Newswire (May 2, 2013)
-
PR Newswire (Apr 30, 2013)
-
-
-
PR Newswire (Apr 22, 2013)
-
-
-
-
-
-
PR Newswire (Mar 12, 2013)
-
PR Newswire (Mar 11, 2013)
-
PR Newswire (Mar 6, 2013)
-
PR Newswire (Mar 4, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
-
-
Call Sellers Target PDL BioPharmaoptionMONSTER • Tue, Dec 21, 2010 -
-
-
Highland Capital Wants PDL BioPharma To Hire New AdvisorLon Juricic • Wed, Dec 12, 2007 -
-
PDL BioPharma: Loeb's Third Point Lowers Stake to 5.1%Lon Juricic • Thu, Oct 18, 2007
-
PDL BioPharma Yields To Activists, Stock JumpsLon Juricic • Wed, Oct 3, 2007
-
-
Activist Target PDL BioPharma Under Fire; Loeb And Others Raise the HeatLon Juricic • Thu, Aug 30, 2007
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
4 Undervalued, Highly Shorted Stocks With Strong Sources Of ProfitabilityKapitall • Wed, Dec 26, 2012
-
PDL BioPharma's CEO Discusses Q4 2011 Results - Earnings Call TranscriptThu, Feb 23, 2012
-
PDL Biopharma's CEO Discusses Q2 2011 Results - Earnings Call TranscriptWed, Jul 27, 2011
-
PDL Biopharma's CEO Discusses Q1 2011 Results - Earnings Call TranscriptWed, Apr 27, 2011 • 1 Comment
-
PDL BioPharma CEO Discusses Q4 2010 Results - Earnings Call TranscriptMon, Feb 28, 2011
-
PDL BioPharma CEO Discusses Q3 2010 Results – Earnings Call TranscriptWed, Nov 10, 2010
-
PDL BioPharma, Inc. Q2 2010 Earnings Call TranscriptWed, Jul 28, 2010
-
PDL BioPharma, Inc. Q1 2010 Earnings Call TranscriptThu, Apr 29, 2010
-
PDL BioPharma, Inc. Q4 2009 Earnings Call TranscriptTue, Mar 2, 2010
-
PDL BioPharma Q3 2009 Earnings Call TranscriptWed, Oct 28, 2009
-
at CNBC.com (Wed, 6:58PM)
-
at CNBC.com (Tue, 6:37PM)
-
PR Newswire (May 9, 2013)
-
PR Newswire (May 2, 2013)
-
PR Newswire (Apr 30, 2013)
-
PR Newswire (Apr 22, 2013)
-
PR Newswire (Mar 12, 2013)
-
PR Newswire (Mar 11, 2013)
-
PR Newswire (Mar 6, 2013)
-
PR Newswire (Mar 4, 2013)
-
PR Newswire (Mar 1, 2013)
-
PR Newswire (Feb 25, 2013)
-
PR Newswire (Feb 20, 2013)
-
PR Newswire (Jan 30, 2013)
-
PR Newswire (Jan 30, 2013)
-
PR Newswire (Jan 3, 2013)
-
PR Newswire (Dec 17, 2012)
-
PR Newswire (Dec 6, 2012)
-
PR Newswire (Dec 5, 2012)
-
PR Newswire (Dec 3, 2012)
PDLI vs. ETF Alternatives
Company Description
We were organized as a Delaware corporation in 1986 under the name Protein Design Labs, Inc. In 2006, we changed our name to PDL BioPharma, Inc. Our business is the management of our antibody humanization patents and royalty assets which consist of our Queen et al. patents and license agreements... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, May 9, 4:19 PM PDL Biopharma (PDLI): Q1 EPS of $0.36 in line. Revenue of $91.8M (+19% Y/Y) beats by $110K. (PR). Shares +2% AH. Comment! [Breaking News, Healthcare, On the Move, Earnings]
- Thursday, May 9, 12:10 AM Notable earnings after Thursday’s close: AGO, AIRM, AL, ALIM, ANAC, ASYS, AUQ, BCEI, BID, BPZ, CALL, CPE, DAR, EGY, ET, FTK, FXEN, GXP, KTOS, LLNW, MBI, MCP, MDRX, MDVN, NGVC, NVDA, OPTR, PANL, PCLN, PDLI, PSA, RNDY, SF, SLXP, SQNM, TNGO, UBNT, ZGNX Comment! [Earnings]
- Wednesday, May 8, 5:35 PM Notable earnings after Thursday’s close: AGO, AIRM, AL, ALIM, ANAC, ASYS, AUQ, BCEI, BID, BPZ, CALL, CPE, DAR, EGY, ET, FTK, FXEN, GXP, KTOS, LLNW, MBI, MCP, MDRX, MDVN, NGVC, NVDA, OPTR, PANL, PCLN, PDLI, PSA, RNDY, SF, SLXP, SQNM, TNGO, UBNT, ZGNX Comment! [Earnings]
- Monday, April 22, 7:57 AM PDL BioPharma (PDLI) will provide Avinger with up to $40M of mezzanine financing. The funding will facilitate the development and commercialization of Avinger's lumivascular technologies (catheter systems with imaging capability) used for patients with peripheral artery disease whose hospitalization costs top $21B each year. Comment! [Healthcare]
- Friday, March 1, 4:05 PM PDL BioPharma (PDLI): Q4 EPS of $0.34 beats by $0.03. Revenue of $86M in-line. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Friday, March 1, 12:10 AM Notable earnings after Friday’s close: PDLI, STEC, VECO, VNR Comment! [Earnings]
- Thursday, February 28, 5:35 PM Notable earnings after Friday’s close: PDLI, STEC, VECO, VNR 1 Comment [Earnings]
- Wednesday, January 30, 8:51 AM PDL BioPharma Inc. (PDLI) declares $0.15/share quarterly dividend, in line with previous. Forward yield 8.92%. For shareholders of record Mar. 05. Payable Mar. 12. Ex-div date Mar. 01. The board has declared record and payment dates for next few quarters. (PR) Comment! [Dividends]
- Tuesday, January 15, 2:37 PM PDL BioPharma (PDLI -5.3%) slips after Credit Suisse cut the shares to Neutral on valuation and lowers its price target from $6.50 to $6.00. The firm adds that PDLI lacks significant optionality as new products deliver a finite and relatively short revenue stream. 1 Comment [Healthcare, On the Move]
-
Monday, December 3, 2012, 5:48 PM
After-hours top gainers, as of 5:15 p.m.: ESIO +11.7%. PETS +5.6%. DWA +5.2%. IMUC +3.2%. PACR +3%.
After-hours top losers: PBY -6.4%. PFPT -5.9%. DST -3.9%. PDLI -3.2%. GRMN -2.4%. Comment! [On the Move] - Monday, December 3, 2012, 4:27 PM PDL BioPharma (PDLI) -0.9% AH after announcing CFO Bruce Tomlinson has resigned on account of "personal reasons." A search has begun for a replacement. (PR) 1 Comment [Healthcare]
- Monday, November 5, 2012, 4:44 PM PDL BioPharma (PDLI): Q3 EPS of $0.32 beats by $0.02. Revenue of $85.2M (+2.2% Y/Y) in-line. (PR) Comment! [Earnings, Healthcare]
- Monday, November 5, 2012, 12:10 AM Notable earnings after Monday’s close: ALNY, CF, CLNE, CTRP, CVI, DEPO, ED, ENOC, EOG, ESRX, FIS, FNF, JIVE, LF, LYV, MDR, MED, MM, MMLP, MR, MYGN, NRP, PAA, PDLI, PNG, SBAC, TEG, THQI, TWTC, UAN, VVC, WLT, WTW, XL, Z Comment! [Earnings]
- Sunday, November 4, 2012, 5:35 PM Notable earnings after Monday’s close: ALNY, CF, CLNE, CTRP, CVI, DEPO, ED, ENOC, EOG, ESRX, FIS, FNF, JIVE, LF, LYV, MDR, MED, MM, MMLP, MR, MYGN, NRP, PAA, PDLI, PNG, SBAC, TEG, THQI, TWTC, UAN, VVC, WLT, WTW, XL, Z Comment! [Earnings]
- Thursday, August 2, 2012, 4:11 PM PDL BioPharma (PDLI): Q2 EPS of $0.52 beats by $0.08. Revenue of $12.9M (+3.1% Y/Y) in-line. Shares +1.1% AH. (PR) 1 Comment [Earnings, Healthcare, On the Move]
- Thursday, May 3, 2012, 8:23 PM PDL BioPharma (PDLI): Q1 EPS of $0.29 beats by $0.02. Revenue of $77.3M (-7.2% Y/Y) in-line. (PR) Comment! [Earnings, Healthcare]
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.